A Three‐Dimensional Culture–Drug Sensitivity Test Predicts MDM2 Inhibitor–Sensitivity in SMARCB1 / INI1 ‐Deficient Tumors

Cancer Science · Published 2026-06-26 · DOI 10.1111/cas.70451

Free full text

Authors (13)

Hiroaki Goto, Chiyoko Nishime, Takashi Ohtsu, Mieko Ito, Maiko Sagisaka, Takuya Naruto, Norihiko Kitagawa, Mio Tanaka, Masakatsu Yanagimachi, Yukihiko Hiroshima, Junko Takita, Yasuhide Hayashi, Yohei Miyagi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Goto, H., Nishime, C., Ohtsu, T., et al. (2026). A Three‐Dimensional Culture–Drug Sensitivity Test Predicts MDM2 Inhibitor–Sensitivity in SMARCB1 / INI1 ‐Deficient Tumors. Cancer Science. https://doi.org/10.1111/cas.70451

Related articles